LD-2 disclosure · 1st Quarter - Report
IGM BIOSCIENCES, INC.
via IGM BIOSCIENCES, INC.
Expenses$130Kself-filed spend
Client
- Name
- IGM BIOSCIENCES, INC.
- Location
- California · United States of America
Registrant
- Firm
- IGM BIOSCIENCES, INC.
- Description
- ​Development of engineered IgM antibodies
- Location
- Mountain View, California, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
H.R.2471 - Consolidated Appropriations Act, 2022 COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing
Lobbyistsmr ANDREW WESLEY WOMACK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)